Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma

Biomarkers

Volumn 17, Issue 4, 2012, Pages 372-378

  Zhang, Bin ^a   Zhang, Zhengliang ^b   Zhang, Xufei ^a   Gao, Xu ^c   Kernstine, Kemp H ^d   Zhong, Li ^a,e  

^a HEBEI UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Gastric cancer; Gene expression; Proteomics

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; LYMPHOCYTE ANTIGEN 6 COMPLEX LOCUS K ANTIBODY; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; AGED; ANTIBODIES, NEOPLASM; ANTIGENS, LY; ANTIGENS, NEOPLASM; AREA UNDER CURVE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CLONING, MOLECULAR; ESOPHAGEAL NEOPLASMS; FEMALE; GPI-LINKED PROTEINS; HUMANS; MALE; MIDDLE AGED; ROC CURVE; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84861625984     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.680609     Document Type: Article

References (28)

1. Belousov PV, Kuprash DV, Nedospasov SA, Shebzukhov YV. (2010). Autoantibodies to tumor-associated antigens as cancer biomarkers. Curr Mol Med 10:115-122.
2. Boon T, Old LJ. (1997). Cancer Tumor antigens. Curr Opin Immunol 9:681-683.
3. Caballero OL, Chen YT. (2009). Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100:2014-2021.
4. Chen YT, Scanlan MJ, Venditti CA, Chua R, Theiler G, Stevenson BJ, Iseli C, Gure AO, Vasicek T, Strausberg RL, Jongeneel CV, Old LJ, Simpson AJ. (2005). Identification of cancer/testis-antigen genes by massively parallel signature sequencing. Proc Natl Acad Sci USA 102:7940-7945.
5. de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB, Brakenhoff RH. (2003). Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer 103:768-774.
6. Desmetz C, Cortijo C, Mange A, Solassol J. (2009). Humoral response to cancer as a tool for biomarker discovery. J Proteomics 72:982-988.
7. Finn OJ. (2005). Immune response as a biomarker for cancer detection and a lot more. N Engl J Med 353:1288-1290.
8. Hanash S. (2003). Disease proteomics. Nature 422:226-232.
9. Ishikawa N, Takano A, Yasui W, Inai K, Nishimura H, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y. (2007). Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Cancer Res 67:11601-11611.
10. Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT. (2001). Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 61:2055-2061.
11. Jemal A, Center MM, DeSantis C, Ward EM. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893-1907.
12. Kawaguchi H, Ohno S, Miyazaki M, Hashimoto K, Egashira A, Saeki Watanabe M, Sugimachi K. (2000). CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 89:1413-1417.
13. Lee JW, Lee YS, Yoo KH, Lee KH, Park K, Ahn T, Ko C, Park JH. (2006). LY-6K gene: a novel molecular marker for human breast cancer. Oncol Rep 16:1211-1214.
14. Lin HS, Talwar HS, Tarca AL, Ionan A, Chatterjee M, Ye B, Wojciechowski J, Mohapatra S, Basson MD, Yoo GH, Peshek B, Lonardo F, Pan CJ, Folbe AJ, Draghici S, Abrams J, Tainsky MA. (2007). Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16:2396-2405.
15. Maruyama M, Yoshitake H, Tsukamoto H, Takamori K, Araki Y. (2010). Molecular expression of Ly6k, a putative glycosylphosphatidylinositol- anchored membrane protein on the mouse testicular germ cells. Biochem Biophys Res Commun 402:75-81.
16. Mealy K, Feely J, Reid I, McSweeney J, Walsh T, Hennessy TP. (1996). Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol 22:505-507.
17. Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, Cianfriglia M, Barca S, De Placido S, Martignetti A, Felici F, Cortese R, Monaci P. (2003). Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 106:534-544.
18. Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, Omori T, Sugiura H, Goda K, Kaise M, Inoue H, Ishikawa H, Ochiai A, Shimoda T, Watanabe H, Tajiri H, Saito D. (2010). Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28:1566-1572.
19. Old LJ. (2001). Cancer/testis (CT) antigens - a new link between gametogenesis and cancer. Cancer Immun 1:1.
20. Old LJ, Chen YT. (1998). New paths in human cancer serology. J Exp Med 187:1163-1167.
21. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. (1995). Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810-11813.
22. Scanlan MJ, Simpson AJ, Old LJ. (2004). The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4:1.
23. Tan EM. (2001). Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 108:1411-1415.
24. Tan HT, Low J, Lim SG, Chung MC. (2009). Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276:6880-6904.
25. Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. (2005). Autoantibody signatures in prostate cancer. N Engl J Med 353:1224-1235.
26. Yamabuki T, Takano A, Hayama S, Ishikawa N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Kondo S, Nakamura Y, Daigo Y. (2007). Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67:2517-2525.
27. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. (2006). Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 1:513-519.
28. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. (2005). Using protein microarray as a diagnostic assay or non-small cell lung cancer. Am J Respir Crit Care Med 172:1308-1314.